Page 13 - Les Meilleurs doctors pour votre Biopsie - TOP 423 des médecins

Le médecin est un spécialiste en radiothérapie et oncologue hautement qualifié avec une vaste expérience dans le traitement de divers cancers. Spécialisé dans les techniques avancées de radiothérapie, le médecin a contribué de manière significative à l'amélioration des résultats des patients grâce à des plans de traitement innovants. Le médecin est accrédité par les principaux conseils médicaux et a publié de nombreux articles de recherche dans des revues médicales prestigieuses, enrichissant le domaine de l'oncologie avec des découvertes révolutionnaires.<\/p>

Le médecin est un oncochirurgien très expérimenté, spécialisé dans les techniques chirurgicales avancées pour le traitement du cancer. Avec une expertise étendue dans le domaine, le médecin a contribué de manière significative au développement de protocoles chirurgicaux innovants visant à améliorer les résultats des patients. Le médecin est reconnu pour son engagement envers l'excellence clinique et a publié de nombreux articles de recherche dans des revues médicales prestigieuses. En tant que professeur, le médecin participe activement à la formation de la prochaine génération de chirurgiens, en soulignant l'importance de la précision et des soins centrés sur le patient en oncochirurgie.<\/p>

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Professor Dr. Kurt Rasche is a German pulmonologist with more than 40 years of clinical experience. He is Chief of Pulmonology at Helios University Hospital Wuppertal. He leads the departments of pulmonology, sleep medicine, and ventilation therapy. He also heads the certified Lung Cancer Center.

He is certified in internal medicine, pulmonology, allergology, sleep medicine, and intensive care. His clinical work focuses on diagnosing and treating chronic lung diseases, lung cancer, and sleep-related breathing disorders. He works closely with specialists from other fields to provide coordinated care.

Le médecin est un mammologue très expérimenté, spécialisé dans la chirurgie mammaire. Avec un accent sur les techniques chirurgicales innovantes, le médecin dirige le département de chirurgie mammaire, garantissant des soins et des résultats de premier ordre pour les patients. Le médecin est reconnu pour ses contributions au traitement du cancer du sein et a publié de nombreux articles de recherche dans des revues médicales prestigieuses. Le médecin participe également à des essais cliniques visant à améliorer les thérapies contre le cancer du sein et a reçu de nombreux prix pour son excellence dans la pratique chirurgicale et les soins aux patients.<\/p>

Dr. Do‑young Jeong is an obstetrician‑gynecologist focused on minimally invasive, single‑port, and robotic surgery. Dr. Jeong completed an internship at Seoul National University Hospital. Dr. Jeong completed residency and graduate training at Korea University. Dr. Jeong then completed a fellowship in gynecologic oncology at the National Cancer Center, focusing on uterine and ovarian disease. Dr. Jeong served as director and chief medical officer at MizMedi Hospital and Incheon Sejong Hospital. Dr. Jeong later served as vice president at Dongtan Jeil Hospital. Dr. Jeong is a Clinical Professor at Kyung Hee University Hospital at Gangdong and an Adjunct Professor at Korea University. Dr. Jeong also serves on expert committees for KSGO, MOHW, MFDS, and KHIDI.

Professional memberships include the Korean societies for obstetrics and gynecology, gynecologic endoscopy, gynecologic robotic surgery, and reproductive medicine, as well as ISUOG. Dr. Jeong holds patents for single‑port surgical devices, including a camera, access ring, and irrigation system. Honors include the Korea University Outstanding Resident Award and the KSGE Best Poster Award. Dr. Jeong was first author of SCI‑indexed papers in 2013 and 2014. From 2023 to 2025, Dr. Jeong led studies on da Vinci SP myomectomy and hysterectomy, and on HIFU.

Le médecin est gynécologue spécialisé dans les opérations endoscopiques et laparoscopiques. Avec un accent sur les techniques chirurgicales peu invasives, le médecin est compétent pour réaliser des procédures avancées qui améliorent la récupération et les résultats des patients. Le médecin a une vaste expérience dans la gestion de cas gynécologiques complexes, utilisant des technologies de pointe pour fournir des soins optimaux.<\/p>

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Asist. Prof. Dr. Paul Stanciu is a Consultant Gynaecological Surgeon and subspecialist in Gynaecological Oncology and Robotic Surgery. He has worked in Germany, Ireland, and the UK, including at The Royal Marsden Hospital.

He is the first gynaecologist worldwide accredited by SERGS to operate on two robotic platforms. He is among the few who perform complex minimally invasive procedures, including surgery for endometriosis and fertility-sparing surgery for young cancer patients.

His expertise includes the surgical treatment of benign and malignant gynaecological conditions. He is experienced in advanced laparoscopic surgery and uses innovative techniques published internationally.

Dr. Stanciu is the author or co-author of many scientific articles. He has delivered over 100 presentations at national and international conferences. He holds certifications from SERGS, ESGO, BSCCP, and IOTA, and is an active member of major professional societies.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Le médecin se spécialise en obstétrique et gynécologie avec un accent sur la médecine materno-fœtale et les techniques chirurgicales peu invasives. Avec plus de 20 ans d'expérience, le médecin a contribué à plusieurs études révolutionnaires dans les soins prénatals et a été publié dans de nombreuses revues à comité de lecture. Le médecin est un obstétricien-gynécologue certifié et a reçu de nombreux prix pour l'excellence des soins aux patients.<\/p>

Dr. Shady Mohammed El‑sebai is an interventional radiologist and diagnostic imaging consultant. He is the Consultant and Chief of Interventional Radiology at Sheaf El Orman Oncology Hospital (2021–present). He is also Chief of the Interventional Radiology Unit at the National Cancer Institute, Cairo University (2022–present). He has been a Lecturer in interventional radiology at the National Cancer Institute since 2018. Earlier posts include assistant lecturer and specialist, radiology resident, specialist at Khartoum Breast Care Centre, and specialist and consultant at Techno Scan.

Expertise includes CT‑ and US‑guided true‑cut biopsies and FNAC; transarterial chemoembolization for HCC and for liver, renal, and soft‑tissue tumors; percutaneous nephrostomy and ureteric stents; pigtail drainage; and RF or microwave ablation of hepatic, bone, lung, and thyroid lesions. He also performs PTD and biliary stents; uterine artery embolization; coiling for pelvic varicosities and varicocele; varicose vein ablation and sclerotherapy; and breast procedures (biopsy, markers, wire localization, Mammotome). He is skilled in US, CT, and MRI.

Thomas W. Kraus est un médecin gastro-intestinal renommé en Allemagne, avec plus de 30 ans d'expérience et plus de 3 000 interventions chirurgicales réalisées. Il est spécialisé dans la gestion de la procédure Whipple, l'oncologie de l'estomac et le traitement des maladies du foie. Il est le médecin en chef de la clinique Nordwest à Francfort-sur-le-Main. Le professeur Kraus est membre de plusieurs associations médicales nationales et internationales prestigieuses et a reçu de nombreuses récompenses pour ses réalisations. Il propose un large éventail de services chirurgicaux, notamment la laparotomie, la laparoscopie, la résection radicale, le drainage des maladies inflammatoires, la reconstruction chirurgicale des voies biliaires, le pontage, l'agrafage des voies biliaires endommagées, la correction endoscopique des hernies, et bien d'autres encore.

Urologue, Oncochirurgien